Neuromuscular effects of G93A-SOD1 expression in zebrafish

Molecular Neurodegeneration

Volumn 7, Issue 1, 2012, Pages

  Sakowski, Stacey A ^a   Lunn, J Simon ^a   Busta, Angela S ^b   Oh, Sang Su ^a   Zamora Berridi, Grettel ^a   Palmer, Madeline ^a   Rosenberg, Andrew A ^a   Philip, Stephen G ^a   Dowling, James J ^a,b   Feldman, Eva L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Amyotrophic lateral sclerosis (ALS); Cu 2+ Zn2+ superoxide dismutase (SOD1); G93A SOD1; Motor neuron (MN); Neurodegeneration; Neuromuscular junction; Zebrafish

Indexed keywords

GROWTH FACTOR; MUTANT PROTEIN; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FAMILIAL DISEASE; GENE MUTATION; GENETIC ASSOCIATION; INNERVATION; MOTOR NEURON DISEASE; NERVE FIBER GROWTH; NEUROMUSCULAR SYNAPSE; NEUROPATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL; ZEBRA FISH;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; HUMANS; MOTOR ACTIVITY; MOTOR NEURONS; MUTATION; NERVE DEGENERATION; NEUROMUSCULAR JUNCTION; SUPEROXIDE DISMUTASE; ZEBRAFISH;

DANIO RERIO;

EID: 84865564198     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-7-44     Document Type: Article

References (67)

1. ALS: a disease of motor neurons and their nonneuronal neighbors. Boillee S, Vande Velde C, Cleveland DW, Neuron 2006 52 39 59 10.1016/j.neuron.2006.09. 018 17015226
2. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. Ilieva H, Polymenidou M, Cleveland DW, J Cell Biol 2009 187 761 772 10.1083/jcb.200908164 19951898
3. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD, Exp Neurol 2004 185 232 240 10.1016/j.expneurol. 2003.10.004 14736504
4. Axonal degeneration in motor neuron disease. Fischer LR, Glass JD, Neurodegener Dis 2007 4 431 442 10.1159/000107704 17934327
5. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Chen YZ, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, Dierick I, Abel A, Kennerson ML, Rabin BA, et al. Am J Hum Genet 2004 74 1128 1135 10.1086/421054 15106121
6. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, Patterson V, Swingler R, Kieran D, Prehn J, et al. Nat Genet 2006 38 411 413 10.1038/ng1742 16501576
7. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS, Miyamoto N, Showguchi-Miyata J, Okada Y, Singaraja R, et al. Nat Genet 2001 29 166 173 10.1038/ng1001-166 11586298
8. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, et al. Science 2009 323 1205 1208 10.1126/science.1166066 19251627
9. Rethinking ALS: the FUS about TDP-43. Lagier-Tourenne C, Cleveland DW, Cell 2009 136 1001 1004 10.1016/j.cell.2009.03.006 19303844
10. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Munch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld AD, Kurt A, Prudlo J, Peraus G, Hanemann CO, Stumm G, Ludolph AC, Neurology 2004 63 724 726 10.1212/01.WNL.0000134608.83927.B1 15326253
11. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Nishimura AL, Mitne-Neto M, Silva HC, Richieri-Costa A, Middleton S, Cascio D, Kok F, Oliveira JR, Gillingwater T, Webb J, et al. Am J Hum Genet 2004 75 822 831 10.1086/425287 15372378
12. Mutant dynactin in motor neuron disease. Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ, et al. Nat Genet 2003 33 455 456 10.1038/ng1123 12627231
13. Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al. Nature 1993 362 59 62 10.1038/362059a0 8446170
14. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Yang Y, Hentati A, Deng HX, Dabbagh O, Sasaki T, Hirano M, Hung WY, Ouahchi K, Yan J, Azim AC, et al. Nat Genet 2001 29 160 165 10.1038/ng1001-160 11586297
15. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, Yang Y, Fecto F, Shi Y, Zhai H, et al. Nature 2011 477 211 215 10.1038/nature10353 21857683
16. Mutations of optineurin in amyotrophic lateral sclerosis. Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, Kinoshita Y, Kamada M, Nodera H, Suzuki H, et al. Nature 2010 465 223 226 10.1038/nature08971 20428114
17. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, et al. Neuron 2011 72 245 256 10.1016/j.neuron.2011.09.011 21944778
18. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, et al. Neuron 2011 72 257 268 10.1016/j.neuron.2011.09.010 21944779
19. SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments. Joyce PI, Fratta P, Fisher EM, Acevedo-Arozena A, Mamm Genome 2011 22 420 448 10.1007/s00335-011-9339-1 21706386
20. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Li M, Ona VO, Guegan C, Chen M, Jackson-Lewis V, Andrews LJ, Olszewski AJ, Stieg PE, Lee JP, Przedborski S, Friedlander RM, Science 2000 288 335 339 10.1126/science.288.5464.335 10764647
21. Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration. Lunn JS, Sakowski SA, Kim B, Rosenberg AA, Feldman EL, Dev Neurobiol 2009 69 871 884 10.1002/dneu.20747 19672955
22. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, Science 1994 264 1772 1775 10.1126/science.8209258 8209258
23. Unraveling the complexity of amyotrophic lateral sclerosis: recent advances from the transgenic mutant SOD1 mice. Peviani M, Caron I, Pizzasegola C, Gensano F, Tortarolo M, Bendotti C, CNS Neurol Disord Drug Targets 2010 9 491 503 20522008
24. The "dying-back" phenomenon of motor neurons in ALS. Dadon-Nachum M, Melamed E, Offen D, J Mol Neurosci 2011 43 470 477 10.1007/s12031-010-9467-1 21057983
25. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Dupuis L, Loeffler JP, Curr Opin Pharmacol 2009 9 341 346 10.1016/j.coph.2009.03.007 19386549
26. Zebrafish models for the functional genomics of neurogenetic disorders. Kabashi E, Brustein E, Champagne N, Drapeau P, Biochim Biophys Acta 2011 1812 335 345 10.1016/j.bbadis.2010.09.011 20887784
27. In the swim of things: recent insights to neurogenetic disorders from zebrafish. Kabashi E, Champagne N, Brustein E, Drapeau P, Trends Genet 2010 26 373 381 10.1016/j.tig.2010.05.004 20580116
28. Neuromuscular synapses can form in vivo by incorporation of initially aneural postsynaptic specializations. Flanagan-Steet H, Fox MA, Meyer D, Sanes JR, Development 2005 132 4471 4481 10.1242/dev.02044 16162647
29. High-frequency generation of transgenic zebrafish which reliably express GFP in whole muscles or the whole body by using promoters of zebrafish origin. Higashijima S, Okamoto H, Ueno N, Hotta Y, Eguchi G, Dev Biol 1997 192 289 299 10.1006/dbio.1997.8779 9441668
30. Real-time imaging of mitochondria in transgenic zebrafish expressing mitochondrially targeted GFP. Kim MJ, Kang KH, Kim CH, Choi SY, Biotechniques 2008 45 331 334 10.2144/000112909 18778258
31. Promoter analysis in living zebrafish embryos identifies a cis-acting motif required for neuronal expression of GATA-2. Meng A, Tang H, Ong BA, Farrell MJ, Lin S, Proc Natl Acad Sci USA 1997 94 6267 6272 10.1073/pnas.94.12. 6267 9177206
32. Zebrafish survival motor neuron mutants exhibit presynaptic neuromuscular junction defects. Boon KL, Xiao S, McWhorter ML, Donn T, Wolf-Saxon E, Bohnsack MT, Moens CB, Beattie CE, Hum Mol Genet 2009 18 3615 3625 10.1093/hmg/ddp310 19592581
33. Generation and Characterization of a genetic zebrafish model of SMA carrying the human SMN2 gene. le Hao T, Burghes AH, Beattie CE, Mol Neurodegener 2011 6 24 10.1186/1750-1326-6-24 21443782
34. Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. McWhorter ML, Monani UR, Burghes AH, Beattie CE, J Cell Biol 2003 162 919 931 10.1083/jcb.200303168 12952942
35. FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis. Kabashi E, Bercier V, Lissouba A, Liao M, Brustein E, Rouleau GA, Drapeau P, PLoS Genet 2011 7 1002214 10.1371/journal.pgen.1002214 21829392
36. Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish. Lemmens R, Van Hoecke A, Hersmus N, Geelen V, D'Hollander I, Thijs V, Van Den Bosch L, Carmeliet P, Robberecht W, Hum Mol Genet 2007 16 2359 2365 10.1093/hmg/ddm193 17636250
37. Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish. Gros-Louis F, Kriz J, Kabashi E, McDearmid J, Millecamps S, Urushitani M, Lin L, Dion P, Zhu Q, Drapeau P, et al. Hum Mol Genet 2008 17 2691 2702 10.1093/hmg/ddn171 18558633
38. Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Simpson CL, Lemmens R, Miskiewicz K, Broom WJ, Hansen VK, van Vught PW, Landers JE, Sapp P, Van Den Bosch L, Knight J, et al. Hum Mol Genet 2009 18 472 481 18996918
39. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Kabashi E, Lin L, Tradewell ML, Dion PA, Bercier V, Bourgouin P, Rochefort D, Bel Hadj S, Durham HD, Vande Velde C, et al. Hum Mol Genet 2010 19 671 683 10.1093/hmg/ddp534 19959528
40. A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Ramesh T, Lyon AN, Pineda RH, Wang C, Janssen PM, Canan BD, Burghes AH, Beattie CE, Dis Model Mech 2010 3 652 662 10.1242/dmm.005538 20504969
41. Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis. Sakowski SA, Schuyler AD, Feldman EL, Amyotroph Lateral Scler 2009 10 63 73 10.1080/17482960802160370 18608100
42. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P, J Neurosci 2000 20 2534 2542 10729333
43. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. Gould TW, Buss RR, Vinsant S, Prevette D, Sun W, Knudson CM, Milligan CE, Oppenheim RW, J Neurosci 2006 26 8774 8786 10.1523/JNEUROSCI.2315-06.2006 16928866
44. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. Sagot Y, Dubois-Dauphin M, Tan SA, de Bilbao F, Aebischer P, Martinou JC, Kato AC, J Neurosci 1995 15 7727 7733 7472523
45. Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression. Sakowski SA, Heavener SB, Lunn JS, Fung K, Oh SS, Spratt SK, Hogikyan ND, Feldman EL, Gene Ther 2009 16 1292 1299 10.1038/gt.2009.111 19727131
46. Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments. Dupuis L, Echaniz-Laguna A, Curr Drug Targets 2010 11 1250 1261 10.2174/1389450111007011250 20840067
47. The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, Campbell DS, Parant JM, Yost HJ, Kanki JP, Chien CB, Dev Dyn 2007 236 3088 3099 10.1002/dvdy.21343 17937395
48. A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish. Kawakami K, Takeda H, Kawakami N, Kobayashi M, Matsuda N, Mishina M, Dev Cell 2004 7 133 144 10.1016/j.devcel.2004.06.005 15239961
49. Evolution of gait abnormalities in SOD1(G93A) transgenic mice. Mancuso R, Olivan S, Osta R, Navarro X, Brain Res 2011 1406 65 73 21733494
50. Delivery of an adenoviral vector to the crushed recurrent laryngeal nerve. Rubin A, Mobley B, Hogikyan N, Bell K, Sullivan K, Boulis N, Feldman E, Laryngoscope 2003 113 985 989 10.1097/00005537-200306000-00013 12782809
51. Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration. Jang YC, Lustgarten MS, Liu Y, Muller FL, Bhattacharya A, Liang H, Salmon AB, Brooks SV, Larkin L, Hayworth CR, et al. FASEB J 2010 24 1376 1390 10.1096/fj.09-146308 20040516
52. Zebrafish relatively relaxed mutants have a ryanodine receptor defect, show slow swimming and provide a model of multi-minicore disease. Hirata H, Watanabe T, Hatakeyama J, Sprague SM, Saint-Amant L, Nagashima A, Cui WW, Zhou W, Kuwada JY, Development 2007 134 2771 2781 10.1242/dev.004531 17596281
53. Differential requirement for MuSK and dystroglycan in generating patterns of neuromuscular innervation. Lefebvre JL, Jing L, Becaficco S, Franzini-Armstrong C, Granato M, Proc Natl Acad Sci USA 2007 104 2483 2488 10.1073/pnas.0610822104 17284594
54. In vivo imaging of preferential motor axon outgrowth to and synaptogenesis at prepatterned acetylcholine receptor clusters in embryonic zebrafish skeletal muscle. Panzer JA, Song Y, Balice-Gordon RJ, J Neurosci 2006 26 934 947 10.1523/JNEUROSCI.3656-05.2006 16421313
55. The zebrafish ennui behavioral mutation disrupts acetylcholine receptor localization and motor axon stability. Saint-Amant L, Sprague SM, Hirata H, Li Q, Cui WW, Zhou W, Poudou O, Hume RI, Kuwada JY, Dev Neurobiol 2008 68 45 61 10.1002/dneu.20569 17918238
56. Neuromuscular synaptogenesis in wild-type and mutant zebrafish. Panzer JA, Gibbs SM, Dosch R, Wagner D, Mullins MC, Granato M, Balice-Gordon RJ, Dev Biol 2005 285 340 357 10.1016/j.ydbio.2005.06.027 16102744
57. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Wong M, Martin LJ, Hum Mol Genet 2010 19 2284 2302 10.1093/hmg/ddq106 20223753
58. Motor neuron regeneration in adult zebrafish. Reimer MM, Sorensen I, Kuscha V, Frank RE, Liu C, Becker CG, Becker T, J Neurosci 2008 28 8510 8516 10.1523/JNEUROSCI.1189-08.2008 18716209
59. Structural, biochemical, and expression analysis of two distinct insulin-like growth factor I receptors and their ligands in zebrafish. Maures T, Chan SJ, Xu B, Sun H, Ding J, Duan C, Endocrinology 2002 143 1858 1871 10.1210/en.143.5.1858 11956169
60. Kindlin-2 is an essential component of intercalated discs and is required for vertebrate cardiac structure and function. Dowling JJ, Gibbs E, Russell M, Goldman D, Minarcik J, Golden JA, Feldman EL, Circ Res 2008 102 423 431 10.1161/CIRCRESAHA.107.161489 18174465
61. Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. Dowling JJ, Vreede AP, Low SE, Gibbs EM, Kuwada JY, Bonnemann CG, Feldman EL, PLoS Genet 2009 5 1000372 10.1371/journal.pgen.1000372 19197364
62. Westerfield M, The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio rerio) Eugene, OR: The University of Oregon Press 5 2007
63. Membrane traffic and muscle: lessons from human disease. Dowling JJ, Gibbs EM, Feldman EL, Traffic 2008 9 1035 1043 10.1111/j.1600-0854.2008.00716.x 18266915
64. Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. Rouaux C, Panteleeva I, Rene F, de Aguilar JL G, Echaniz-Laguna A, Dupuis L, Menger Y, Boutillier AL, Loeffler JP, J Neurosci 2007 27 5535 5545 10.1523/JNEUROSCI.1139-07.2007 17522299
65. Remote delivery of rAAV-GFP to the rat brainstem through the recurrent laryngeal nerve. Rubin AD, Hogikyan ND, Sullivan K, Boulis N, Feldman EL, Laryngoscope 2001 111 2041 2045 10.1097/00005537-200111000-00032 11801993
66. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Kim H, Kim HY, Choi MR, Hwang S, Nam KH, Kim HC, Han JS, Kim KS, Yoon HS, Kim SH, Neurosci Lett 2010 468 190 194 10.1016/j.neulet.2009.10.074 19879334
67. Neuronal survival following remote adenovirus gene delivery. Boulis NM, Turner DE, Imperiale MJ, Feldman EL, J Neurosurg 2002 96 212 219 12450285